SkinBioTherapeutics

United Kingdom
Macclesfield, England, United Kingdom, SK11 7QJ

Company profile

SkinBioTherapeutics company profile

The SkinBioTherapeutics platform applies research discoveries made on the activities of lysates derived from probiotic bacteria when applied to the skin. The Company has shown that the SkinBiotix® platform can improve the barrier effect of skin models, improve repair, and reduce bacterial load.

Business identity

Contact email
[email protected]
Phone number
+01614682760
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0-$1M
Founded
2015-01-01, Year

Headquarters

Postal code
SK11 7QJ
Country code
GB
Continent
Europe

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
4
Total equity funding
$7.1M
Last funding
Post IPO Equity / $2M / 2024-08-02
Last equity funding
Post IPO Equity / $2M
Investors
3
Lead investors
3
Founders
1
Articles
29
Exited on
2017-04-06

Founders and investors

Founders

Catherine O'Neill

Lead investors

Cynosure CapitalPremier Miton InvestorsSeneca Partners

Investors

Cynosure CapitalPremier Miton InvestorsSeneca Partners